Optimize Financial Inc Day One Biopharmaceuticals, Inc. Transaction History
Optimize Financial Inc
- $133 Billion
- Q4 2024
A detailed history of Optimize Financial Inc transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Optimize Financial Inc holds 15,487 shares of DAWN stock, worth $189,870. This represents 0.15% of its overall portfolio holdings.
Number of Shares
15,487Holding current value
$189,870% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
79.7MCall Options Held
130KPut Options Held
217K-
Atlas Venture Life Science Advisors, LLC6.43MShares$78.8 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$71.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$70.6 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$59.8 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$55.6 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $901M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...